GRFS Stock Price, Chart, Stats & News

Grifols, S.A.
Save
GRFS chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 38.38% |
Operating margin | 16.96% |
Pretax margin | 8.18% |
Net margin | 5.34% |
Effective tax rate | 18.75% |
ROA | 2.03% |
ROE | 7.54% |
D/E | 1.66x |
Interest coverage ratio | 2.09x |
GRFS valuation
P/E | 8.29x |
P/S | 0.73x |
P/B | 0.84x |
P/CF | 4.27x |
P/FCF | 7.11x |
P/OCF | 4.27x |
PEG | 1.75x |
EV multiple | -1.51x |
About
Grifols, S. A., a company founded in 1940 and headquartered in Barcelona, Spain, specializes in the development, manufacture, and distribution of therapeutic products, with a primary focus on those derived from human plasma. Its operations are organized into several divisions.
Similar securities
Based on sector and market capitalization
Report issue











